Brief: Sesen Bio Inc- On May 13, Co Requested Type A Meeting With U.S. FDA

Carisma Therapeutics

16/05/2022 13:14

May 16 (Reuters) - Sesen Bio Inc  SESN.O :
    * SESEN BIO INC- ON MAY 13, CO REQUESTED TYPE A MEETING WITH
THE
U.S. FDA
    * SESEN BIO-TYPE A MEETING TO DISCUSS REMAINING ITEMS OF
ADDITIONAL PHASE 3 CLINICAL TRIAL, CO EVALUATING FOR POTENTIAL
RESUBMISSION OF BLA FOR VICINEUM


Further company coverage:  SESN.O 

 ((Reuters.Briefs@thomsonreuters.com;))